| Code | CSB-RA004966MA3HU |
| Size | $49.9 |
| Order now | |
| Promotion | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
CD8A serves as a critical co-receptor on cytotoxic T lymphocytes, working alongside the T cell receptor to recognize antigens presented by MHC class I molecules. This interaction is fundamental to adaptive immune responses, making CD8A an essential marker for identifying and studying cytotoxic T cell populations in immunology research, from basic T cell biology to immuno-oncology investigations.
This recombinant monoclonal antibody against human CD8A offers the reproducibility that demanding research requires. Generated through recombinant technology using clone 9F1, the antibody provides sequence-defined consistency between lots, eliminating the variability that can complicate longitudinal studies or multi-site collaborations. The human IgG2 isotype format and affinity chromatography purification ensure a reliable reagent for your experimental workflows.
Functional validation demonstrates strong binding performance in ELISA applications, with EC50 values ranging from 11.49 to 20.78 ng/mL when tested against immobilized human CD8A protein. This high-affinity binding supports detection across a broad working dilution range of 1:5000 to 1:50000, giving you flexibility to optimize conditions for your specific experimental setup while maintaining cost-effective reagent use.
The antibody is supplied in a liquid format containing 50% glycerol in PBS at pH 7.4 with 0.03% Proclin 300 as preservative, ready for immediate use without reconstitution. For optimal stability, store at -20°C or -80°C upon receipt and minimize freeze-thaw cycles.
Whether you are characterizing T cell subsets, investigating immune checkpoint pathways, or developing immunological assays, this CD8A recombinant antibody provides a dependable tool for your immunology research applications.
There are currently no reviews for this product.